Insider Cluster (2 insiders) ·Filed Jul 2, 2026

HALO

HALOZYME THERAPEUTICS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $624K total
Actionable Insight • Neutral

The insider cluster is dominated by non-cash grants and routine director sales that are immaterial relative to HALO's $9.1B market cap. No C-suite executive sold shares on the open market. The $624K in open-market sales is noise. Monitor the next 10-Q for any fundamental changes, but this cluster provides no actionable trading signal.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+60d
HALO ▲ +45.02% at T+60d
NEUTRAL call ✓ call won +45.02% · α vs SPY +42.01% · entry $79.45 → $115.22
Next anchor: T+1d due 3mo ago
Entry anchored
Jul 1, 03:59 PM ET
via exchange tick
T+1d
—
call — · α —
—
due 3mo ago
T+5d
-1.04%
call -1.04% · α -1.98%
$78.62
settled 3mo ago
T+20d
+4.85%
call +4.85% · α +5.26%
$83.30
settled 2mo ago
T+60d
+45.02%
call +45.02% · α +42.01%
$115.22
settled 7d ago

Price Chart

Loading chart...

Executive Summary

Two HALO directors sold a combined $624K in open-market sales over a 3-day window, with the bulk ($548K) from Director Krishnan Mahesh following a derivative exercise. The total sales represent ~0.007% of HALO's $9.1B market cap — a trivial amount. The cluster is dominated by non-cash grants/awards to the CFO and EVP, which carry no economic signal. The open-market sales are small relative to company size and are likely routine portfolio diversification.

Key Financial Metrics

Direction
selling
Total Value
$624.0K
Insiders
2

Key Facts

  • Two directors sold a combined $624K in open-market sales over a 3-day window (June 29 – July 1, 2026).
  • Total open-market sales represent ~0.007% of HALO's $9.1B market cap — a trivial amount.
  • The cluster is dominated by non-cash grants/awards to the CFO and EVP (208,041 shares at $0), which carry no economic signal.
  • Director Krishnan Mahesh's sale ($548K) followed a derivative exercise — a common pattern for tax diversification, not a bearish signal.
  • Director Connaughton Bernadette sold a small position ($124K) — likely routine portfolio management.
  • No C-suite executives made open-market sales; the CFO's transactions were all non-cash grants and awards.

Financial Impact

Total open-market sales of $624K represent ~0.007% of HALO's $9.1B market cap — a trivial amount.

insider ownershipfloat

Risk Factors

  • No material risk identified from this insider activity — the cluster is too small to be informative.
  • Director sales could increase if the stock continues to appreciate, but current levels are trivial.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
69% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-HALO-1783059252185
6 reports for HALO
Performance horizon
Filters
Rows
Reports for HALO — sortable, filterable
TypeNow
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$106.12 $112.45▲ +5.96%▲ +5.96%$109.25 (+2.94%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$78.62 $85.76▲ +9.08%▲ +6.84%$109.25 (+38.95%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$79.45 $83.30▲ +4.85%▲ +5.26%$109.25 (+37.50%)
Jun 4, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.60 $79.45▲ +10.96%▲ +12.34%$109.25 (+52.58%)
Apr 30, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$63.66 $68.18▲ +7.10%▲ +2.13%$109.25 (+71.61%)
Mar 23, 2026
27w ago
DEFA14A
NEUTRAL ★ 2/10
$62.04 $68.40▲ +10.25%▲ +1.35%$109.25 (+76.09%)
Showing 6 of 6

US Market Status

Market Open — Closes in 3h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026